Atom Investors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$647K Sell
27,678
-214,581
-89% -$3.88M 0.05% 428
2025
Q4
$3.44M Buy
242,259
+213,069
+730% +$4.03M 0.27% 125
2025
Q3
$723K Sell
29,190
-44,205
-60% -$986K 0.05% 303
2025
Q2
$1.67M Sell
73,395
-98,457
-57% -$2.33M 0.15% 183
2025
Q1
$5.21M Buy
171,852
+73,615
+75% +$2.8M 0.64% 34
2024
Q4
$3.9M Buy
98,237
+63,888
+186% +$2.88M 0.48% 52
2024
Q3
$2.18M Sell
34,349
-22,645
-40% -$1.63M 0.23% 146
2024
Q2
$3.85M Buy
+56,994
New +$3.98M 0.38% 82
2024
Q1
Sell
-13,828
Closed -$1.08M 565
2023
Q4
$1.08M Buy
13,828
+2,758
+25% +$204K 0.19% 175
2023
Q3
$778K Buy
+11,070
New +$827K 0.18% 163
2022
Q3
Sell
-8,009
Closed -$542K 277
2022
Q2
$542K Buy
+8,009
New +$559K 0.24% 109
2021
Q2
Sell
-19,938
Closed -$1.14M 240
2021
Q1
$1.14M Buy
+19,938
New +$1.08M 0.19% 105
2019
Q1
Sell
-54,203
Closed -$1.39M 496
2018
Q4
$1.39M Buy
+54,203
New +$1.88M 0.14% 228

Other funds holding ACHC

Atom Investors's ACHC Position: Q1 2026 in Review

Atom Investors reduced its Acadia Healthcare (ACHC) stake by 89% in Q1 2026, selling an estimated $3.88M and leaving 27,678 shares worth $647K. The position accounts for 0.05% of the portfolio, ranked #428.

Atom Investors first reported a position in ACHC in Q4 2018 and has held it in 13 quarters since. The position peaked at $5.21M in Q1 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Atom Investors held 27,678 shares of Acadia Healthcare worth $647K as of Q1 2026.
  • Atom Investors sold 214,581 Acadia Healthcare shares in Q1 2026, an estimated $3.88M.
  • Acadia Healthcare made up 0.05% of Atom Investors's portfolio in Q1 2026, its #428 holding.
  • Atom Investors first reported a position in Acadia Healthcare in Q4 2018 and has held it in 13 quarters since.
  • Atom Investors's Acadia Healthcare position peaked at $5.21M in Q1 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.